Acuitas Therapeutics and Partners Publish Comparative Study of AAV and mRNA-LNP Delivery with in Situ Sequencing for Spatial Genome Editing

Acuitas Therapeutics and Partners Publish Comparative Study of AAV and mRNA-LNP Delivery with in Situ Sequencing for Spatial Genome Editing

Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems, recently announced the publication of a new study in Nature Biomedical Engineering, titled “Spatial profiling of gene editing by in situ sequencing in mice and macaques.” Co-authored by Acuitas scientists Ying Tam, Sean Semple, Thomas Chamberlain, and Jennifer Moon – together with partners from the University of Zurich and the University of Pennsylvania – the stu…